Insulet | Чистый Доход



Net Income Изменить Дата
Abbott USD 9.23B 7.58B 2024-12
Align Technology USD 103.81M 12.16M 2024-12
AtriCure USD -15568000 7.72M 2024-12
Avanos Medical USD -397300000 401.6M 2024-12
Baxter International USD -512000000 652M 2024-12
Becton, Dickinson and Co. USD 303M 97M 2024-12
Boston Scientific USD 566M 97M 2024-12
Cardinal Health USD 400M 16M 2024-12
Cooper Companies USD 104.3M 13.2M 2025-01
Dexcom USD 151.7M 17.1M 2024-12
Edwards Lifesciences USD 385.6M 2.69B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Globus Medical USD 26.5M 25.33M 2024-12
ICU Medical USD -23828000 9.15M 2024-12
Insulet USD 100.7M 23.2M 2024-12
Integra LifeSciences USD 19.43M 30.13M 2024-12
J&J USD 3.43B 737M 2024-12
Masimo USD -349600000 359.4M 2024-12
Medtronic USD 1.29B 25M 2025-01
Merit Medical Systems USD 27.95M 497K 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Solventum Corp 31M 91M 2024-12
Stryker USD 546M 288M 2024-12
Tandem Diabetes Care USD 755K 24.01M 2024-12
Teleflex USD -136656000 247.66M 2024-12
West Pharmaceutical Services USD 130.1M 5.9M 2024-12
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12



Insulet Чистый Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.